Transfemoral aortic valve implantation: Bleeding events, related costs and outcomes

Journal of Thrombosis and Thrombolysis

Volumn 35, Issue 4, 2013, Pages 469-475

  Reinöhl, Jochen ^a   Gutmann, Anja ^a   Kollum, Marc ^a,c   Von Zur Mühlen, Constantin ^a   Baumbach, Hardy ^b   Avlar, Melanie ^a   Moser, Martin ^a   Bode, Christoph ^a   Zehender, Manfred ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b ROBERT BOSCH HOSPITAL   (Germany)

^c HBH Kliniken   (Germany)

Author keywords

Bleeding; Costs; Economic evaluation; Transcatheter aortic valve implantation (TAVI); Transcatheter aortic valve replacement (TAVR); Transfemoral aortic valve implantation (TF AVI); Valve Academic Research Consortium (VARC)

Indexed keywords

AGED; ANGIODYSPLASIA; AORTA VALVE PROSTHESIS; ARTERY PERFORATION; ARTICLE; BLEEDING; CONTROLLED STUDY; FALSE ANEURYSM; FEMALE; FEMORAL ARTERY; GASTROINTESTINAL HEMORRHAGE; GERMANY; HEALTH CARE UTILIZATION; HEMATOMA; HEMATURIA; HOSPITAL COST; HUMAN; INTENSIVE CARE UNIT; LENGTH OF STAY; LUNG HEMORRHAGE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RETROPERITONEAL HEMORRHAGE; TRANSCATHETER AORTIC VALVE IMPLANTATION; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; AORTIC VALVE STENOSIS; CARDIAC CATHETERIZATION; COSTS AND COST ANALYSIS; FEMALE; HEART VALVE PROSTHESIS; HOSPITAL MORTALITY; HUMANS; MALE; POSTOPERATIVE HEMORRHAGE; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 84878487494     PISSN: 09295305     EISSN: 1573742X     Source Type: Journal    
DOI: 10.1007/s11239-012-0829-0     Document Type: Article

References (32)

1. Makkar RR, Fontana GP, Jilaihawi H, Kapadia S, Pichard AD, Douglas PS, Thourani VH, Babaliaros VC, Webb JG, Herrmann HC, Bavaria JE, Kodali S, Brown DL, Bowers B, Dewey TM, Svensson LG, Tuzcu M, Moses JW, Williams MR, Siegel RJ, Akin JJ, Anderson WN, Pocock S, Smith CR, Leon MB (2012) Transcatheter aortic-valve replacement for inoperable severe aortic stenosis. N Engl J Med 366:1696-1704
2. Smith CR, Leon MB, Mack MJ, Miller DC, Moses JW, Svensson LG, Tuzcu EM, Webb JG, Fontana GP, Makkar RR, Williams M, Dewey T, Kapadia S, Babaliaros V, Thourani VH, Corso P, Pichard AD, Bavaria JE, Herrmann HC, Akin JJ, Anderson WN, Wang D, Pocock SJ (2011) Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med 364:2187-2198
3. Kodali SK, Williams MR, Smith CR, Svensson LG, Webb JG, Makkar RR, Fontana GP, Dewey TM, Thourani VH, Pichard AD, Fischbein M, Szeto WY, Lim S, Greason KL, Teirstein PS, Malaisrie SC, Douglas PS, Hahn RT, Whisenant B, Zajarias A, Wang D, Akin JJ, Anderson WN, Leon MB (2012) Two year outcomes after transcatheter or surgical aortic-valve replacement. N Engl J Med 366:1686-1695
4. Leon MB, Smith CR, Mack M, Miller DC, Moses JW, Svensson LG, Tuzcu EM, Webb JG, Fontana GP, Makkar RR, Brown DL, Block PC, Guyton RA, Pichard AD, Bavaria JE, Herrmann HC, Douglas PS, Petersen JL, Akin JJ, Anderson WN, Wang D, Pocock S (2010) Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med 363:1597-1607
5. Cribier A, Eltchaninoff H, Bash A, Borenstein N, Tron C, Bauer F, Derumeaux G, Anselme F, Laborde F, Leon MB (2002) Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description. Circulation 106:3006-3008
6. Nuis RJ, Piazza N, Van Mieghem NM, Otten AM, Tzikas A, Schultz CJ, van der Boon R, van Geuns RJ, van Domburg RT, Koudstaal PJ, Kappetein AP, Serruys PW, de Jaegere PP (2011) In-hospital complications after transcatheter aortic valve implantation revisited according to the valve academic research consortium definitions. Catheter Cardiovasc Interv 78:457-467
7. Thomas M, Schymik G, Walther T, Himbert D, Lefevre T, Treede H, Eggebrecht H, Rubino P, Colombo A, Lange R, Schwarz RR, Wendler O (2011) One year outcomes of cohort 1 in the Edwards sapien aortic bioprosthesis european outcome (source) registry: the european registry of transcatheter aortic valve implantation using the Edwards sapien valve. Circulation 124:425-433
8. Van Mieghem NM, Nuis RJ, Piazza N, Apostolos T, Ligthart J, Schultz C, de Jaegere PP, Serruys PW (2010) Vascular complications with transcatheter aortic valve implantation using the 18 fr medtronic corevalve system: the rotterdam experience. EuroIntervention 5:673-679
9. Piazza N, Grube E, Gerckens U, den Heijer P, Linke A, Luha O, Ramondo A, Ussia G, Wenaweser P, Windecker S, Laborde JC, de Jaegere P, Serruys PW (2008) Procedural and 30-day outcomes following transcatheter aortic valve implantation using the third generation (18 fr) corevalve revalving system: results from the multicentre, expanded evaluation registry 1-year following ce mark approval. EuroIntervention 4:242-249
10. Lefevre T, Kappetein AP, Wolner E, Nataf P, Thomas M, Schachinger V, De Bruyne B, Eltchaninoff H, Thielmann M, Himbert D, Romano M, Serruys P, Wimmer-Greinecker G (2011) One year follow-up of the multi-centre european partner transcatheter heart valve study. Eur Heart J 32:148-157
11. Wenaweser P, Pilgrim T, Roth N, Kadner A, Stortecky S, Kalesan B, Meuli F, Bullesfeld L, Khattab AA, Huber C, Eberle B, Erdos G, Meier B, Juni P, Carrel T, Windecker S (2011) Clinical outcome and predictors for adverse events after transcatheter aortic valve implantation with the use of different devices and access routes. Am Heart J 161:1114-1124
12. Genereux P, Head SJ, Van Mieghem NM, Kodali S, Kirtane AJ, Xu K, Smith C, Serruys PW, Kappetein AP, Leon MB (2012) Clinical outcomes after transcatheter aortic valve replacement using valve academic research consortium definitions: a weighted meta-analysis of 3,519 patients from 16 studies. J Am Coll Cardiol 59:2317-2326
13. Tamburino C, Capodanno D, Ramondo A, Petronio AS, Ettori F, Santoro G, Klugmann S, Bedogni F, Maisano F, Marzocchi A, Poli A, Antoniucci D, Napodano M, De Carlo M, Fiorina C, Ussia GP (2011) Incidence and predictors of early and late mortality after transcatheter aortic valve implantation in 663 patients with severe aortic stenosis. Circulation 123:299-308
14. Rao SV, Kaul PR, Liao L, Armstrong PW, Ohman EM, Granger CB, Califf RM, Harrington RA, Eisenstein EL, Mark DB (2008) Association between bleeding, blood transfusion, and costs among patients with non-st-segment elevation acute coronary syndromes. Am Heart J 155:369-374
15. Weintraub WS, Mahoney EM, Lamy A, Culler S, Yuan Y, Caro J, Gabriel S, Yusuf S (2005) Long-term cost-effectiveness of clopidogrel given for up to one year in patients with acute coronary syndromes without ST-segment elevation. J Am Coll Cardiol 45:838-845
16. Kessler DP, Kroch E, Hlatky MA (2011) The effect of bivalirudin on costs and outcomes of treatment of st-segment elevation myocardial infarction. Am Heart J 162:494-500 e492
17. Stone GW, McLaurin BT, Cox DA, Bertrand ME, Lincoff AM, Moses JW, White HD, Pocock SJ, Ware JH, Feit F, Colombo A, Aylward PE, Cequier AR, Darius H, Desmet W, Ebrahimi R, Hamon M, Rasmussen LH, Rupprecht HJ, Hoekstra J, Mehran R, Ohman EM (2006) Bivalirudin for patients with acute coronary syndromes. N Engl J Med 355:2203-2216
18. Cohen DJ, Lincoff AM, Lavelle TA, Chen HL, Bakhai A, Berezin RH, Jackman D, Sarembock IJ, Topol EJ (2004) Economic evaluation of bivalirudin with provisional glycoprotein iib/iiia inhibition versus heparin with routine glycoprotein iib/iiia inhibition for percutaneous coronary intervention: results from the replace-2 trial. J Am Coll Cardiol 44:1792-1800
19. Pinto DS, Stone GW, Shi C, Dunn ES, Reynolds MR, York M, Walczak J, Berezin RH, Mehran R, McLaurin BT, Cox DA, Ohman EM, Lincoff AM, Cohen DJ (2008) Economic evaluation of bivalirudin with or without glycoprotein iib/iiia inhibition versus heparin with routine glycoprotein IIb/IIIa inhibition for early invasive management of acute coronary syndromes. J Am Coll Cardiol 52:1758-1768
20. Allareddy V, Ward MM, Ely JW, Levett J (2007) Impact of complications on outcomes following aortic and mitral valve replacements in the United States. J Cardiovasc Surg (Torino) 48:349-357
21. Cohn LH, Adams DH, Couper GS, Bichell DP, Rosborough DM, Sears SP, Aranki SF (1997) Minimally invasive cardiac valve surgery improves patient satisfaction while reducing costs of cardiac valve replacement and repair. Ann Surg 226:421-426 discussion 427-428
22. Caro JJ, Migliaccio-Walle K, O'Brien JA (1996) The cost of treating heart valve related complications. J Heart Valve Dis 5:122-127
23. Grube E, Schuler G, Buellesfeld L, Gerckens U, Linke A, Wenaweser P, Sauren B, Mohr FW, Walther T, Zickmann B, Iversen S, Felderhoff T, Cartier R, Bonan R (2007) Percutaneous aortic valve replacement for severe aortic stenosis in high-risk patients using the second- and current third-generation self-expanding corevalve prosthesis: device success and 30-day clinical outcome. J Am Coll Cardiol 50:69-76
24. Otten AM, van Domburg RT, van Gameren M, Kappetein AP, Takkenberg JJ, Bogers AJ, Serruys PW, de Jaegere PP (2008) Population characteristics, treatment assignment and survival of patients with aortic stenosis referred for percutaneous valve replacement. EuroIntervention 4:250-255
25. Delgado V, Ng AC, Shanks M, van der Kley F, Schuijf JD, van de Veire NR, Kroft L, de Roos A, Schalij MJ, Bax JJ (2010) Transcatheter aortic valve implantation: role of multimodality cardiac imaging. Expert Rev Cardiovasc Ther 8:113-123
26. Rodes-Cabau J (2012) Transcatheter aortic valve implantation: current and future approaches. Nat Rev Cardiol 9:15-29
27. Leon MB, Piazza N, Nikolsky E, Blackstone EH, Cutlip DE, Kappetein AP, Krucoff MW, Mack M, Mehran R, Miller C, Morel MA, Petersen J, Popma JJ, Takkenberg JJ, Vahanian A, van Es GA, Vranckx P, Webb JG, Windecker S, Serruys PW (2011) Standardized endpoint definitions for transcatheter aortic valve implantation clinical trials: a consensus report from the valve academic research consortium. Eur Heart J 32:205-217
28. Kramer N (2009) Strategisches kostenmanagement im krankenhaus: neue konzeptionen erforderlich. Das Krankenhaus 11:1036-1044
29. Vogl M (2012) Assessing drg cost accounting with respect to resource allocation and tariff calculation: the case of Germany. Health Econ Rev 2:15
30. Institut für das Entgeltsystem im Krankenhaus: Handbuch ur Kalkulation von Fallkosten Version 3.0 (2007). Deutsche Krankenhaus Verlagsgesellschaft GmbH, Düsseldorf
31. Ducrocq G, Francis F, Serfaty JM, Himbert D, Maury JM, Pasi N, Marouene S, Provenchere S, Iung B, Castier Y, Leseche G, Vahanian A (2010) Vascular complications of transfemoral aortic valve implantation with the Edwards sapien prosthesis: incidence and impact on outcome. EuroIntervention 5:666-672
32. Kahlert P, Al-Rashid F, Weber M, Wendt D, Heine T, Kottenberg E, Thielmann M, Kuhl H, Peters J, Jakob HG, Sack S, Erbel R, Eggebrecht H (2009) Vascular access site complications after percutaneous transfemoral aortic valve implantation. Herz 34:398-408